ResearcherSichuan UniversityActive in the last 2 years

Wenhao Hu

ORCID-verified (high confidence)As of 13 November 2026

Matched on ORCID iD 0000-0003-1511-2614; OpenAlex author ID A5074406685.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers: 2 (first author 0, last author 1)
Pancreatic cancer trials: 0
Pancreatic cancer grants: 0
Collaborators: 4

Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper

Papers 2

Closest collaborators

The 4 strongest of 4 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Lin Lü · 1 shared paper, 2025
- Paper Advanced pancreatic cancer treated with camrelizumab combined with apatinib: A case report. DOI 10.4251/wjgo.v17.i2.100724 ↗
Yun-Hao Luo · 1 shared paper, 2025
- Paper Advanced pancreatic cancer treated with camrelizumab combined with apatinib: A case report. DOI 10.4251/wjgo.v17.i2.100724 ↗
Jiamin Liang · 1 shared paper, 2024
- Paper [Effects of 4-hydroxy-2(3H)-benzoxazolone on proliferation and apoptosis of pancreatic cancer L3.6 cells]. DOI 10.19540/j.cnki.cjcmm.20240115.703 ↗
Liyun Wang · 1 shared paper, 2024
- Paper [Effects of 4-hydroxy-2(3H)-benzoxazolone on proliferation and apoptosis of pancreatic cancer L3.6 cells]. DOI 10.19540/j.cnki.cjcmm.20240115.703 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.